Yinzhu Jin, MPH (she/her/hers)

Research Specialist
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
Boston, United States

Disclosure information not submitted.

Presentation(s):

• A scalable approach to assess the safety of novel systemic treatments for atopic dermatitis in clinical practice: First analysis cycle of the ADVANCES sequential monitoring system

  Monday, August 26, 2024
  1:45 PM – 2:00 PM CEST

• Comparative safety of biologic and targeted-synthetic DMARDs in patients with rheumatoid arthritis: a multi-database real-world cohort study

  Monday, August 26, 2024
  5:20 PM – 5:25 PM CEST